Search for: "CENTOCOR RESEARCH "
Results 1 - 20
of 31
Sort by Relevance
|
Sort by Date
8 Dec 2023, 7:58 am
Genentech, 2004, Centocor v. [read post]
9 Apr 2015, 11:59 am
Rev. 1571, 1582, 1607 (2009), which mentions -- I thank Josh Walker, Mark Lemley, and the underwriters of the Stanford IP Litigation Clearinghouse for making this research possible-- but does not mention Eolas or Ariad. [read post]
6 Nov 2014, 5:00 am
Centocor, Inc. v. [read post]
12 Aug 2014, 8:00 pm
Centocor sought [...] review under [§ 146] of the decisions of the [Board] in an interference between [Centocor's] U.S. [read post]
2 Jul 2014, 1:42 pm
Janssen Biotech and Centocor Biologics (Fed. [read post]
29 May 2014, 5:00 am
Centocor, Inc., 2007 WL 4119054, at *1 (E.D. [read post]
3 Mar 2013, 12:06 pm
Patil 48/MUMNP/2010 HADASIT MEDICAL RESEARCH Abandoned Dr. [read post]
28 Dec 2012, 1:57 pm
Centocor, Inc. v. [read post]
10 Sep 2012, 7:19 am
Drafted by Derik Sanders (dtsanders@smu.edu), a 2014 Juris Doctor Candidate at SMU Dedman School of Law and research assistant to Professor Sarah Tran. [read post]
11 Jan 2012, 2:02 pm
Centocor Ortho Biotech, Inc. v. [read post]
10 Jan 2012, 11:58 pm
Centocor Ortho Biotech, Inc. v. [read post]
7 Dec 2011, 11:32 am
Centocor, Inc., 2008 WL 2565065, at *4 (D.N.J. [read post]
11 Nov 2011, 11:55 am
At worst, a terse denial of the motion without prejudice would have been warranted.But no, Murthy leapt in with both feet, preempting, as it were, the prerogatives of the Texas Supreme Court to declare the law of Texas:Given the underlying justifications for the learned intermediary doctrine, the Court believes that the Texas Supreme Court will likely agree with the Court of Appeals’ reasoning in Centocor, Inc.2011 U.S. [read post]
31 Jul 2011, 9:28 pm
Centocor, Inc., 409 F.3d 1376, 1378 (Fed. [read post]
10 Jun 2011, 4:09 pm
" Centocor Ortho Biotech, Inc. v. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
17 Mar 2011, 11:55 am
By 1985, many researchers had produced antibodies to human TNF-a. [read post]
4 Mar 2011, 9:18 pm
: Albany Molecular Research v Alphapharm / ????? [read post]
1 Mar 2011, 8:38 pm
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and pay-for-delay agreements… [read post]
